The US Food and Drug Administration recently asked Endo Pharmaceuticals to take their “uncrushable” opioid painkiller, Opana ER, off the market because of public health concerns about the potential for abuse. “FDA requests removal of Opana ER for risks related to abuse” Not only is this the first time the FDA has recalled a drug […]